A randomized-controlled, open label, two arm study to evaluate safety and efficacy of a New antimicrobial wound dressing (VELVERT) compared to the Standard dressing (SD) in infected wound.

Datt Mediproduct Pvt Ltd0 个研究点目标入组 70 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•1. Subject with cellulitis, necrotizing fasciitis, venous ulcer, and bedsores.
•2. Subjects with Infected wounds with or without trauma.
•3. Male and female of age group between 18 to 70 years (Adult, Older Adult).
•4. Subjects must be able to read and understand informed consent and sign the informed consent to provide data for the study.
•5. Subjects who allow their data to be collected for the study at predefined follow-up

•Subject unwilling or unable to comply with the follow up visits necessary for data
•collection.
•2. Subject found positive for HIV and HPV.
•3. Concurrent participation in another clinical trial that involves an investigational
•drug or dressing that would interfere with This Study.
•4. Pregnant females.
•5. Subjects with osteomyelitis of the underlying bone.
•6. Subject with Immunosuppression, corticosteroids or chemotherapy.
•7. Subject with Diabetic foot ulcer and/or burn.
•8. Patient with a severe comorbid disorder, not expected to survive more than

发起方

Datt Mediproduct Pvt Ltd